Chander Prakash Puri

Chander Prakash Puri

Director Additional Director DIN 06886988
DIN 06886988 First appointment Jul 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Chander Prakash Puri

Data last updated:

Chander Prakash Puri was an Additional Director at Aspira Pathlab & Diagnostics Limited (2016) and Additional Director at Yashraj Biotechnology Limited (2017). The companies operate in Healthcare and Life Sciences.

DIN 06886988
Primary Designation Additional Director
Industry Healthcare
First Appointment 29 Jul 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aspira Pathlab & Diagnostics Limited L85100MH1973PLC289209
Additional Director29 Jul 20161973₹22.39 Cr (FY 2025)Active
Yashraj Biotechnology Limited U73100MH1999PLC119769
Additional Director13 May 20171999₹88.45 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aspira Pathlab & Diagnostics Limited
Yashraj Biotechnology Limited
Premium access

Shareholding and investment profile for Chander Prakash Puri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chander Prakash Puri

Chander Prakash Puri was first appointed on 29 Jul 2016 as Additional Director at Aspira Pathlab & Diagnostics Limited. The most recent appointment on record is 13 May 2017 at Yashraj Biotechnology Limited.

Chander Prakash Puri held 2 earlier board appointments: Aspira Pathlab & Diagnostics Limited (Additional Director, 29 Jul 2016 to 30 Sep 2016); Yashraj Biotechnology Limited (Additional Director, 13 May 2017 to 28 Sep 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available